Barbara E. Mahon, MD

Adjunct Professor, Epidemiology

Barbara Mahon
715 Albany St Talbot Building


Dr. Mahon received her MD and clinical training in pediatrics from the University of California, San Francisco and her MPH from the University of California, Berkeley. She trained in CDC’s Epidemic Intelligence Service (EIS). Dr. Mahon is deputy chief of the Enteric Diseases Epidemiology and Surveillance Branch at the Centers for Disease Control and Prevention (CDC). The branch is responsible for national surveillance for enteric diseases. It conducts epidemiologic studies of the burden, trends, and food source attribution of foodborne diseases caused by Listeria , Salmonella, and E. coli O157, among other pathogens. The branch’s work also focuses on vulnerable populations, including older adults, young children, and other groups, with the goal of creating knowledge needed to protect people by preventing disease. Dr. Mahon has a broad background in infectious disease epidemiology, having worked on foodborne diseases, vaccine-preventable diseases, and sexually transmitted diseases in academic and industry positions as well as in government.

Other Positions

  • Adjunct Assistant Professor, General Pediatrics, Pediatrics, Boston University Chobanian & Avedisian School of Medicine


  • University of California San Francisco, MD
  • University of California, Berkeley, MPH
  • Harvard University, AB


  • Published on 6/24/2022

    Gold JAW, Kelleher J, Magid J, Jackson BR, Pennini ME, Kushner D, Weston EJ, Rasulnia B, Kuwabara S, Bennett K, Mahon BE, Patel A, Auerbach J. Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability - United States, December 23, 2021-May 21, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 24; 71(25):825-829. PMID: 35737571.

    Read at: PubMed
  • Published on 1/14/2022

    Barrett CE, Koyama AK, Alvarez P, Chow W, Lundeen EA, Perrine CG, Pavkov ME, Rolka DB, Wiltz JL, Bull-Otterson L, Gray S, Boehmer TK, Gundlapalli AV, Siegel DA, Kompaniyets L, Goodman AB, Mahon BE, Tauxe RV, Remley K, Saydah S. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):59-65. PMID: 35025851.

    Read at: PubMed
  • Published on 1/11/2022

    Cohn AC, Mahon BE, Walensky RP. One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality. JAMA. 2022 Jan 11; 327(2):119-120. PMID: 34932067.

    Read at: PubMed
  • Published on 12/15/2021

    Dolan SB, Mahon BE, Dowell SF, Zaidi A. Toward Understanding Death. Clin Infect Dis. 2021 12 15; 73(Suppl_5):S341-S342. PMID: 34910167.

    Read at: PubMed
  • Published on 12/1/2021

    Mahon BE, Simon J, Widdowson MA, Samai M, Rogier E, Legardy-Williams J, Liu K, Schiffer J, Lange J, DeByle C, Pinner R, Schuchat A, Slutsker L, Goldstein S. Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein. J Infect Dis. 2021 12 01; 224(11):1907-1915. PMID: 34013349.

    Read at: PubMed
  • Published on 5/14/2021

    Morgan OW, Aguilera X, Ammon A, Amuasi J, Fall IS, Frieden T, Heymann D, Ihekweazu C, Jeong EK, Leung GM, Mahon B, Nkengasong J, Qamar FN, Schuchat A, Wieler LH, Dowell SF. Disease surveillance for the COVID-19 era: time for bold changes. Lancet. 2021 06 19; 397(10292):2317-2319. PMID: 34000258.

    Read at: PubMed
  • Published on 2/2/2021

    Grais RF, Kennedy SB, Mahon BE, Dubey SA, Grant-Klein RJ, Liu K, Hartzel J, Coller BA, Welebob C, Hanson ME, Simon JK. Estimation of the correlates of protection of the rVSV?G-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials. Lancet Microbe. 2021 Feb; 2(2):e70-e78. PMID: 35544244.

    Read at: PubMed
  • Published on 7/28/2020

    Jacobs Slifka KM, Blackstock A, Nguyen V, Schwensohn C, Gieraltowski L, Mahon BE. Estimating the Incubation Period of Salmonella Urinary Tract Infections Using Foodborne Outbreak Data. Foodborne Pathog Dis. 2020 10; 17(10):628-630. PMID: 32735492.

    Read at: PubMed
  • Published on 7/3/2020

    Hallowell BD, Carlson CM, Jacobs JR, Pomeroy M, Steinberg J, Tenforde MW, McDonald E, Foster L, Feldstein LR, Rolfes MA, Haynes A, Abedi GR, Odongo GS, Saruwatari K, Rider EC, Douville G, Bhakta N, Maniatis P, Lindstrom S, Thornburg NJ, Lu X, Whitaker BL, Kamili S, Sakthivel SK, Wang L, Malapati L, Murray JR, Lynch B, Cetron M, Brown C, Roohi S, Rotz L, Borntrager D, Ishii K, Moser K, Rasheed M, Freeman B, Lester S, Corbett KS, Abiona OM, Hutchinson GB, Graham BS, Pesik N, Mahon B, Braden C, Behravesh CB, Stewart R, Knight N, Hall AJ, Killerby ME. Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020. Emerg Infect Dis. 2020 Sep; 26(9):1998-2004. PMID: 32620182.

    Read at: PubMed
  • Published on 6/26/2020

    Klugman KP, Zewdu S, Mahon BE, Dowell SF, Srikantiah P, Laserson KF, Tappero JW, Zaidi AK, Mundel T. Younger ages at risk of Covid-19 mortality in communities of color. Gates Open Res. 2020; 4:69. PMID: 32715283.

    Read at: PubMed

View 107 more publications: View full profile at BUMC

View all profiles